Kyntra Bio Inc (KYN) Form 4 Filed on June 17
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowOn June 17, Kyntra Bio Inc (KYN) filed Form 4 with the SEC, reflecting insider trading activity. The form disclosed stock transactions and potential changes in beneficial ownership among executive officers. These filings are significant as they provide transparency on insider actions which can influence investor perceptions. The specific details of the stock transactions made on this date were not included in the article.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
